INCY
Incyte Corporation · Healthcare · Biotechnology
TECHSellZACKSHold
R500#456 today
$115.30
-1.57% today · -6.93% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- INCY −1.57% on the last session vs SPY +0.74%: −2.3 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 64 big drops in the past 5 years, INCY typically gained 0.7% over the next week (median) and was higher 56% of the time; half the outcomes fell between -1.7% and +2.4%. An ordinary week: +0.1%. Among S&P 500 stocks after big drops, that ranks #128 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 27
In 23 days
estimated date
EPS estimate
−$3.55
−$4.24 to −$2.34 · 17 analysts
Revenue estimate
$1.5B
$1.4B to $1.5B
Track record
5/8 beats
last 8 reports · moved ±6.6% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 BMO | 2Q2026 | $2.15 | $3.09 | +$0.94 (+43.9%) beat | $1.7B | +9.3% +9.1 vs SPY | +0.1% | -0.4% |
| Apr 28, 2026 BMO | 1Q2026 | $1.34 | $1.81 | +$0.47 (+35.1%) beat | $1.3B | +2.1% +2.6 vs SPY | -1.0% | +1.5% |
| Feb 10, 2026 BMO | 4Q2025 | $1.92 | $1.80 | −$0.12 (−6.1%) miss | $1.5B | -8.2% -8.0 vs SPY | -5.5% | -7.2% |
| Oct 28, 2025 BMO | 3Q2025 | $1.64 | $2.26 | +$0.62 (+38.0%) beat | $1.4B | -1.5% -1.8 vs SPY | -1.0% | +9.1% |
| Jul 29, 2025 BMO | $1.47 | $1.57 | +$0.10 (+6.8%) beat | — | +10.3% +10.6 vs SPY | +2.6% | +11.2% | |
| Apr 29, 2025 BMO | $1.03 | $1.16 | +$0.13 (+12.6%) beat | — | +1.5% +0.9 vs SPY | -0.2% | +4.3% | |
| Feb 10, 2025 BMO | $1.55 | $1.43 | −$0.12 (−7.7%) miss | — | -7.9% -8.5 vs SPY | -1.5% | -5.0% | |
| Oct 29, 2024 BMO | $1.09 | $1.07 | −$0.02 (−1.8%) miss | — | +12.0% +11.9 vs SPY | +2.8% | +15.3% | |
| Jul 30, 2024 BMO | $1.11 | −$1.82 | −$2.93 (<−100%) miss | — | -1.2% -0.7 vs SPY | +1.1% | -9.6% | |
| Apr 30, 2024 BMO | $0.83 | $0.64 | −$0.19 (−22.9%) miss | — | -1.0% +0.6 vs SPY | -4.1% | +2.9% | |
| Feb 13, 2024 BMO | $1.15 | $1.06 | −$0.09 (−7.8%) miss | — | +2.6% +4.0 vs SPY | +3.8% | +1.7% | |
| Oct 31, 2023 BMO | $1.07 | $1.10 | +$0.03 (+2.8%) beat | — | +3.4% +2.8 vs SPY | -0.4% | +4.6% | |
| Aug 1, 2023 BMO | $0.87 | $0.99 | +$0.12 (+13.8%) beat | — | -0.1% +0.2 vs SPY | +2.8% | +1.9% | |
| May 2, 2023 BMO | $0.74 | $0.37 | −$0.37 (−50.0%) miss | — | -7.1% -6.0 vs SPY | -9.6% | -12.7% | |
| Feb 7, 2023 BMO | $0.57 | $0.62 | +$0.05 (+8.8%) beat | — | -4.0% -5.3 vs SPY | -1.0% | -5.1% | |
| Nov 1, 2022 BMO | $0.71 | $0.60 | −$0.11 (−15.5%) miss | — | +3.5% +4.0 vs SPY | +1.6% | +2.1% | |
| Aug 2, 2022 BMO | $0.75 | $1.01 | +$0.26 (+34.7%) beat | — | -6.2% -5.6 vs SPY | -4.4% | -4.4% | |
| May 3, 2022 BMO | $0.69 | $0.55 | −$0.14 (−20.3%) miss | — | +1.5% +1.0 vs SPY | +0.1% | -4.5% | |
| Feb 8, 2022 BMO | $0.87 | $0.10 | −$0.77 (−88.5%) miss | — | -4.5% -5.3 vs SPY | -3.7% | -10.0% | |
| Nov 2, 2021 BMO | $0.76 | $1.18 | +$0.42 (+55.3%) beat | — | -8.5% -8.9 vs SPY | -5.5% | -4.1% | |
| Aug 3, 2021 BMO | $0.74 | $0.80 | +$0.06 (+8.1%) beat | — | — | — | — | |
| May 4, 2021 BMO | $0.64 | $0.67 | +$0.03 (+4.7%) beat | — | — | — | — | |
| Feb 9, 2021 BMO | $0.77 | $0.93 | +$0.16 (+20.8%) beat | — | — | — | — | |
| Nov 5, 2020 BMO | $0.76 | $0.23 | −$0.53 (−69.7%) miss | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | −$3.55 (17) | −$4.24 – −$2.34 | -257% | -339.5% | ▲0 ▼8 | $1.5B | +8% |
| Next quarter · Dec 31, 2026 | $1.93 (17) | $1.62 – $2.56 | +7% | -7.2% | ▲3 ▼5 | $1.5B | +1% |
| Current year · Dec 31, 2026 | $3.37 (20) | $2.31 – $4.42 | -50% | -56.4% | ▲0 ▼11 | $5.9B | +16% |
| Next year · Dec 31, 2027 | $8.78 (21) | $7.53 – $9.90 | +161% | -5.7% | ▲2 ▼9 | $6.3B | +5% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.